F
FranchiseChuno
Sign InCreate AccountList Your Franchise
Dr Lal PathLabs

Dr Lal PathLabs Franchise

Healthcare & PharmacyEst. 1949Delhi

Revenue-share collection-centre franchise of listed Dr Lal PathLabs: about ₹3–4 L, 200–250 sq ft; 7,727 patient service centres (Mar 2026).

Dr Lal PathLabs franchise at a glance (terms checked Sept 2026)

Taking franchiseesModels: UnitTerms checked Sept 2026

Investment

₹3 L - ₹4 L

Below the category (typical ₹14.5 L–₹33.44 L, median ₹21.43 L, 8 verified brands)

Ongoing take

Not published

Franchise fee

Not published

Payback

about 20–40 months*

* Not verified — the brand doesn't publish this; the figure comes from other published sources or FranchiseChuno's estimate (see "Reported elsewhere" and "Our estimates" below). Real numbers can differ.

74Strong · provisionalFranchiseChuno Score · 53% of data verified
  • Legal or regulatory action on record — see Reputation & News
  • Disputes with franchisees: None found (records checked Sep 2026)
  • Profit or loss: Profit of ₹509.8 Cr in FY26
  • Company standing: Active and up to date with the registrar

Franchisor strength isn't franchisee profit — check real outlet numbers.

Outlets

7,727 (brand claim)

What we couldn't verify

  • • Outlet closures
  • • Franchisee satisfaction
  • • Outlet claim matches reality
  • • Ongoing take

Ask before you sign

  1. Speak to at least 3 franchisees who have run an outlet for 2+ years and see their actual monthly sales and profit — a franchisor making money doesn't mean its franchisees do.
  2. Ask for the one-time franchise fee in writing, and whether any part is refundable.
  3. Ask for the royalty and any marketing-fund fee, and how they're calculated (on sales or profit).

Franchise terms checked against Dr Lal PathLabs's official franchise page on 27 Sept 2026. Figures marked * aren't published by the brand — they come from other published sources or our own estimate, and aren't verified.

Ways to Partner with Dr Lal PathLabs

1 partner model published by the brand. Figures it doesn't publish are left blank.

Unit franchise

Collection centre (PSC)

Investment
₹3 L – ₹4 L
Space
200 sq ft – 250 sq ft
Royalty / margin
Revenue share: the company books the test revenue and pays the franchisee its share monthly (rate not published)
Who it suits
A self-motivated entrepreneur; medical background preferred

Exclusive Dr Lal PathLabs collection centre; samples go to the company's labs for testing.

Our Estimates

FranchiseChuno estimate

Dr Lal PathLabs doesn't publish these, so here is our best read of the market and how we got there. They are our estimates, not the brand's figures — use them to plan, then confirm the real numbers in writing.

  • Collection centre's share of test revenue

    about 20–30% of billed tests*

    Dr Lal PathLabs doesn't publish the share. Its FY26 accounts show ₹402.4 Cr paid to collection centres and channel partners — 14.6% of consolidated revenue from operations (₹2,762.9 Cr), which also includes its own labs, home collection and B2B work that pay no franchise share. The share on tests booked at a franchised centre is therefore well above 14.6%; we put it at about 20–30%. Confirm the actual rate in the agreement.

    Analyst judgement · Sep 2026

  • Average payout per collection centre

    ~₹30,000–45,000 a month*

    ₹402.4 Cr of FY26 fees spread over 7,727 PSCs is about ₹43,000 a month per centre if PSCs received all of it (FY25: ₹341.9 Cr over 6,607 PSCs, also about ₹43,000); some goes to pick-up-point partners, so the typical centre likely earns less — about ₹30,000–45,000 a month before its own rent and staff. Centres vary widely with footfall.

    Unit-economics model · Sep 2026

  • Payback on a ₹3–4 L collection centre

    about 20–40 months*

    Taking ₹30,000–45,000 a month of revenue share, less roughly ₹20,000–30,000 for a small ground-floor rent and one phlebotomist/front-desk staffer, leaves about ₹10,000–15,000 a month in a middle case; that recovers ₹3–4 L in roughly 20–40 months (₹3 L ÷ ₹15,000 = 20; ₹4 L ÷ ₹10,000 = 40). A centre with low footfall and high rent may not pay back at all.

    Unit-economics model · Sep 2026

Unit Economics

Mixed sources

How Dr Lal PathLabs says an outlet's numbers work. These are illustrations, not guarantees — check them against existing franchisees before you sign.

Collection centre (PSC)

Fees paid to all collection centres and channel partners, network-wideConsolidated expense line — the total the company paid out to collection centres and channel partners, about 14.6% of revenue from operations (₹2,762.9 Cr). It is not a per-centre figure and includes pick-up-point partners.
4,02,39,90,000 INR
Fees paid to all collection centres and channel partners, network-wideConsolidated expense line — the total the company paid out to collection centres and channel partners, about 13.9% of revenue from operations (₹2,461.4 Cr). It is not a per-centre figure and includes pick-up-point partners.
3,41,65,90,000 INR

Reputation & News

4 red flags to check

What the press, courts and real franchisees or customers have said about Dr Lal PathLabs — summarised by us, with every source linked.

  • Legal / regulatory· Jun 2025

    Consumer commission upholds ₹3.5 L compensation over a wrong test report

    The Delhi State Consumer Disputes Redressal Commission dismissed Dr Lal PathLabs's appeal and upheld ₹3.5 L compensation to a patient whose urea report wrongly showed dangerously high levels, leading to emergency care. The original award dated from August 2014; the appeal ruling came in May 2025.

    Source: LawChakra
  • In the news· Nov 2015

    IPO prospectus flagged allegations against a Jalandhar franchisee

    In its Nov 2015 prospectus the company disclosed press reports alleging that a franchisee in Jalandhar swapped blood samples to match donor and recipient DNA reports for kidney transplants; it said the allegations were unconfirmed and no investigation had been started against the company. The same document disclosed a 2015 Odisha police (Special Task Force) inquiry into alleged illegal kidney transplants linked to tests done at its laboratory, in which documents were seized; it said no further communication had followed.

    Source: Dr Lal PathLabs red herring prospectus (SEBI), Nov 2015
  • Legal / regulatory· Jul 2013

    Chandigarh commission upholds compensation over wrong allergy report

    The Chandigarh State Consumer Commission dismissed Dr Lal PathLabs's appeal in 2013 and upheld ₹50,000 compensation to a patient whose test report wrongly indicated a wheat allergy.

    Source: Indian Kanoon — State Consumer Commission, UT Chandigarh
  • In the news· Oct 2020

    TechCrunch: patient data left on an unsecured cloud server

    TechCrunch reported in Oct 2020 that Dr Lal PathLabs had stored spreadsheets of patient bookings — names, addresses, phone numbers and the tests booked, some with COVID-19 remarks — in a cloud storage bucket without a password. A security researcher said it held millions of bookings; the company shut access after being told and said it was investigating.

    Source: TechCrunch
Show 2 more
  • In the news· Jul 2026

    Q1 FY27 call: more labs, radiology pilots and a Ghana acquisition

    On the July 2026 earnings call, CEO Shankha Banerjee said the company plans to add 12–15 labs in FY27 and 3–4 radiology centres. Management guided revenue growth towards the mid-teens and announced an 80% stake purchase in Sunshine Healthcare, Ghana.

    Source: Investing.com (earnings call transcript)
  • In the news· Feb 2024

    CARE Ratings cites franchisee network and market position

    CARE Ratings' press release lists the company's leading position, strong brand and franchisee model among its rating strengths. It also notes 277 labs, 5,102 PSCs and 10,938 pick-up points as of March 2023, and B2C revenue staying above 70% of sales.

    Source: CARE Ratings

Sales by region, FY23

RegionShare of sales
North62%
West16%
East14%
South6%

Source: CARE Ratings press release (Feb 2024)

Key Terms at Dr Lal PathLabs

The clauses that shape day-to-day running and your exit — read these before the fee.

Payments to the brand
Collection-centre franchises run on a revenue share: the company records the centre's gross test revenue and pays the franchisee its specified share monthly (IPO prospectus, 2015). The share isn't published.
Renewal
Collection-centre agreements are exclusive and typically run five to nine years (IPO prospectus, 2015).
Non-compete
Franchisees may not do pathology tests or related work themselves or with third parties during the agreement and for two years after it ends (IPO prospectus, 2015).
Who pays for what
The franchisee finds the premises, provides basic diagnostic equipment and, in some cases, hires phlebotomists and front-office staff; the company gives technical, personnel and marketing support and sometimes supplies consumables (IPO prospectus, 2015).
Other terms
Two partner agreements seen in Delhi High Court orders send disputes to a sole arbitrator in Delhi: a 2015 revenue-sharing agreement names Delhi as the venue, and a 2016 sample-collection MoU names New Delhi as the place of arbitration. Neither is shown to be a collection-centre franchise agreement; the company doesn't publish its current franchise contract.

Legal & Contract Summary

Key contract terms at a glance — read before you sign.

Agreement Type

Not specified

Contract Duration

—

Renewal Available

—

Territory Exclusivity

—

Non-Compete Clause

—

Exit Clause

—

Who Can Apply for Dr Lal PathLabs

Conditions the brand sets for partners, and the licences the business needs.

  • Premises: About 200–250 sq ft on the ground floor with a toiletRequired
  • Background: Medical background preferredPreferred
  • Profile: A self-motivated entrepreneurRequired

About the Brand

Brand USP

Samples collected at your centre go to Dr Lal PathLabs's own network of 312 clinical labs, 53 of them NABL-accredited (FY26 annual report).

Franchising Since1982
HeadquartersDelhi
Dr Lal PathLabs is a listed pathology and diagnostics chain that traces its roots to a Delhi lab started by Dr. (Major) S.K. Lal in 1949; the company was incorporated in 1995 and listed in December 2015. Its FY26 annual report counts 312 clinical labs, 7,727 patient service centres (PSCs) and 13,935 pick-up points as of Mar 2026, up from 6,607 PSCs a year earlier. Filings show FY26 consolidated total income of ₹2,864.2 Cr, net profit of ₹509.8 Cr and no bank borrowings at year-end. The franchise on offer is an exclusive Dr Lal PathLabs collection centre: patients' samples are collected at your centre and tested in the company's labs. The company says it began franchising collection centres in 1982. It puts the minimum investment at around ₹3–4 L and asks for about 200–250 sq ft on the ground floor with a toilet, preferring someone with a medical background. Its 2015 IPO prospectus says collection-centre franchises run on a revenue share — the company books the full test revenue and pays the franchisee its share monthly — on exclusive agreements of five to nine years with a two-year non-compete after exit. What to watch: the company doesn't publish the revenue-share rate, fee, payback or current agreement terms; the contract details above date from 2015. It paid ₹402.4 Cr in fees to collection centres and channel partners across the network in FY26, but that says nothing about what one centre earns — check real centre numbers with existing franchisees. Consumer commissions have ordered it to pay compensation over wrong test reports (₹3.5 L upheld in Delhi in 2025), TechCrunch reported in 2020 that it had left patient booking data on an unsecured cloud server, and it has taken business partners to arbitration over dues.

Why invest in Dr Lal PathLabs?

- Listed company (NSE/BSE) with FY26 consolidated total income of ₹2,864.2 Cr and net profit of ₹509.8 Cr per its annual report (the franchisor's figures, not a centre's); rated CARE AA+; Stable (Mar 2026) - Low published entry cost: about ₹3–4 L and 200–250 sq ft on the ground floor for a collection centre - Network grew from 4,731 PSCs in FY22 to 7,727 in FY26, per its annual reports

Dr Lal PathLabs by the Numbers

Source marked on each figure

1949, Delhi

Founded

Brand claim

312

Clinical labs · Mar 2026

Company filing

7,727

Patient service centres · Mar 2026

Company filing

13,935

Pick-up points · Mar 2026

Company filing

53

NABL-accredited labs · Mar 2026

Company filing

28

Countries of operation · Sep 2026

Brand claim

30.3 million in FY26

Patients served · Mar 2026

Company filing

December 2015

Listed since

Company filing

Dr Lal PathLabs Outlet Network

Outlet count over time

  1. Mar 20213,705

    FY21 · media.lalpathlabs.com

  2. Mar 20224,731

    FY22 · media.lalpathlabs.com

  3. Mar 20235,102

    FY23 · media.lalpathlabs.com

  4. Mar 20245,762

    FY24 · media.lalpathlabs.com

  5. Mar 20256,607

    FY25 · media.lalpathlabs.com

  6. Mar 20267,727

    FY26 · media.lalpathlabs.com

  7. Mar 2013776

    FY13 PSCs · sebi.gov.in

  8. Mar 201348

    FY13 PSCs · sebi.gov.in

  9. Mar 20141,009

    FY14 PSCs · sebi.gov.in

  10. Mar 201455

    FY14 PSCs · sebi.gov.in

  11. Mar 20151,271

    FY15 PSCs · sebi.gov.in

  12. Mar 201569

    FY15 PSCs · sebi.gov.in

  13. Sep 20151,475

    Sep 2015 PSCs · sebi.gov.in

  14. Sep 201579

    Sep 2015 PSCs · sebi.gov.in

These counts come from different sources — brand claims, press reports and store locators — so they aren't a like-for-like series. Treat the brand's own claims as the upper end.

Cities with Outlets

Show all 55 cities
Agartala, TripuraAgra, Uttar PradeshAhmedabad, GujaratAmbala, HaryanaAmritsar, PunjabBangalore, KarnatakaBhopal, Madhya PradeshBhubaneswar, OdishaBilaspur, ChhattisgarhChandigarh, ChandigarhChennai, Tamil NaduDehradun, UttarakhandDelhi, DelhiDhanbad, JharkhandFaridabad, HaryanaGaya, BiharGhaziabad, Uttar PradeshGurgaon, HaryanaHaridwar, UttarakhandHowrah, West BengalHyderabad, TelanganaJabalpur, Madhya PradeshJaipur, RajasthanJalandhar, PunjabJammu, Jammu and KashmirJamshedpur, JharkhandJodhpur, RajasthanKanpur, Uttar PradeshKochi, KeralaKolkata, West BengalKota, RajasthanLucknow, Uttar PradeshLudhiana, PunjabMangaluru, KarnatakaMeerut, Uttar PradeshMohali, PunjabMumbai, MaharashtraMysuru, KarnatakaNagpur, MaharashtraNashik, MaharashtraNoida, Uttar PradeshPanipat, HaryanaPatna, BiharPrayagraj, Uttar PradeshPune, MaharashtraRaipur, ChhattisgarhRanchi, JharkhandShillong, MeghalayaShimla, Himachal PradeshSilchar, AssamSiliguri, West BengalSrinagar, Jammu and KashmirUdaipur, RajasthanVadodara, GujaratVaranasi, Uttar Pradesh

Cities with Outlets

55 cities
Has an outlet
Major city, no outlet listed
Click a city to explore

Company Financials

Brand-level, publicly reported

The franchisor's own company health — separate from what a single franchise outlet earns.

Revenue (FY26)

₹2864.18 Cr

Net profit (FY26)

₹509.75 Cr

Total funding raised

$13.9M+

Employees (May 2026)

5,205

Notable investors

WestBridge CapitalTA AssociatesPeak XV PartnersLife Insurance Corporation of IndiaJashvik Capital

Source: Dr Lal PathLabs annual report 2025-26 — audited consolidated total income and profit

Source: Tracxn — Dr Lal PathLabs, funding and headcount (Sep 2026)

A profitable franchisor doesn't mean profitable franchisees. These are the company's numbers, not an outlet's. A franchisor can grow on fees and supplies while outlets struggle — talk to existing franchisees and see their accounts before you decide.

Company Health Check

What Dr Lal PathLabs's franchisor company has filed with the registrar and the courts — the checks a lawyer would run before you sign.

Status with the registrar
Active
Annual filings
Up to date
Last AGM
25 Jul 2026
Paid-up capital
₹167.55 Cr
Auditor
Deloitte Haskins & Sells LLP

Group companies

  • Paliwal Diagnostics Pvt LtdSubsidiary · 80%
  • Chanre Laboratory Pvt LtdSubsidiary · 70%
  • Pathlabs Unifiers Pvt LtdSubsidiary · 100%
  • Dr. Lal Ventures Pvt LtdSubsidiary · 100%
  • Centrapath Labs Pvt LtdSubsidiary · 70%
  • APRL Pathlabs Pvt LtdSubsidiary · 80%

Source: FY26 annual report (borrowings nil at 31 Mar 2026, consolidated; paid-up capital after the Dec 2025 1:1 bonus issue; CARE issuer rating upgraded 25 Mar 2026; 32nd AGM held 25 Jul 2026); Tracxn — MCA master data (Active, compliant as of 13 Dec 2025; 3 registered charges totalling ₹225.06 Cr on the MCA register, which are not drawn debt) (checked Jul 2026)

Full company recordsFinancials year by year, registered details, leadership and timelineShow

Dr Lal PathLabs Financials Over Time

Figures for the brand, from filed or reported accounts.

FY19
₹1249.37 Cr
Profit ₹200.47 Cr
FY20
₹1385.4 Cr▲ 11%
Profit ₹227.59 Cr
FY21
₹1632.6 Cr▲ 18%
Profit ₹296.48 Cr
FY22
₹2139.95 Cr▲ 31%
Profit ₹350.29 Cr
FY23
₹2058.6 Cr▼ 4%
Profit ₹241.08 Cr
FY24
₹2295.81 Cr▲ 12%
Profit ₹362.29 Cr
FY25
₹2554.82 Cr▲ 11%
Profit ₹492.25 Cr
FY26
₹2864.18 Cr▲ 12%
Profit ₹509.75 Cr

Source: Tracxn — Dr. Lal PathLabs Ltd filings · Tracxn — Dr. Lal PathLabs Ltd filings; EBITDA from the FY26 annual report's financial highlights · Dr Lal PathLabs annual report 2025-26

A profitable franchisor doesn't mean profitable franchisees. These are the company's numbers, not an outlet's. A franchisor can grow on fees and supplies while outlets struggle — talk to existing franchisees and see their accounts before you decide.

Company Profile

The legal entity behind the brand, its leadership, and its official channels.

Registered name
Dr. Lal PathLabs Limited
Company type
Public Listed
CIN
L74899DL1995PLC065388
Incorporated
14 Feb 1995
Headquarters
Delhi

Leadership

  • DDr. Arvind LalExecutive Chairman
  • SShankha BanerjeeCEO
  • VVed Prakash GoelGroup CFO and CEO, International Business

Social presence

FacebookXLinkedInYouTubeAppApp

Company details source: Tracxn — company filings

Dr Lal PathLabs Timeline

  1. 1949

    Founded

    Dr. (Major) S.K. Lal starts pathology services and a blood bank in Delhi.

  2. 1982

    Collection-centre franchising begins

    The company says it began franchising collection centres in 1982.

  3. 1995

    Incorporated

    Incorporated as Dr Lal PathLabs Private Ltd.

  4. 2000

    NABL accreditation

    Hanuman Road lab in Delhi receives NABL accreditation.

  5. 2002

    CAP accreditation

    Hanuman Road lab receives international accreditation from CAP.

  6. 2005

    WestBridge Capital invests

    Private equity investment by WestBridge Capital.

  7. 2008

    Paliwal acquisition

    Acquires Paliwal Medicare and Paliwal Diagnostics.

  8. 2010

    National Reference Lab

    National Reference Lab set up in Delhi.

  9. Dec 2015

    IPO

    Shares listed on the stock exchanges.

  10. 2018

    Kolkata reference lab

    Regional Reference Lab commissioned in Kolkata.

  11. FY22

    Suburban Diagnostics acquired

    Acquires Suburban Diagnostics to strengthen presence in western India.

    Source
  12. Mar 2026

    Credit rating upgraded

    CARE Ratings upgrades the issuer rating to CARE AA+; Stable from CARE AA; Stable.

  13. Jul 2026

    Ghana acquisition approved

    Board approves buying 80% of Sunshine Healthcare Limited, Ghana, and 30% of Neuome Technologies.

    Source
  14. FY27Announced plan

    Plan: 12–15 new labs and 3–4 radiology centres

    Stated by management on the Q1 FY27 earnings call (Jul 2026).

    Source

FranchiseChuno Analysis

Our analysis of verified data

How Dr Lal PathLabs looks once the numbers are checked side by side.

  • •Investment below the Healthcare & Pharmacy medianMidpoint ₹3.5 L vs a category median of ₹21.4 L across brands on FranchiseChuno.
  • ✓The franchisor company is profitableIts latest filed accounts show a net profit. That's the franchisor's money, not yours: a profitable franchisor doesn't mean its franchisees make money. Check real outlet numbers before you invest.
  • ✓44 years of franchisingFranchising since 1982, with 7,727 outlets.
  • !3 red flags in the news or public discussionSee Reputation & News below, and ask the brand to address each one.

Data completeness

55%

  • ✓ Terms checked against the brand's own page
  • ✓ Published investment (not an estimate)
  • ○ Franchise fee
  • ○ Royalty
  • ○ ROI or payback claim
  • ○ Agreement term
  • ○ Training details
  • ✓ Outlet cities verified
  • ✓ Company financials
  • ✓ Legal entity
  • ✓ News & public opinion checked

Ask Before You Sign

Questions tailored to what Dr Lal PathLabs does and doesn't publish.

  1. 1Speak to at least 3 franchisees who have run an outlet for 2+ years and see their actual monthly sales and profit — a franchisor making money doesn't mean its franchisees do.
  2. 2Ask for the one-time franchise fee in writing, and whether any part is refundable.
  3. 3Ask for the royalty and any marketing-fund fee, and how they're calculated (on sales or profit).
  4. 4Ask for the agreement term, renewal fee and exit or transfer terms.
  5. 5Ask whether you get an exclusive territory, and how large it is.
  6. 6Ask the brand to respond to each red flag listed under Reputation & News.
  7. 7Have a lawyer review the franchise agreement before paying anything.
  8. 8Visit 2–3 existing outlets and speak to their owners without the brand present.
Running the outletSpace, staff, launch steps, training, support and who does whatShow

Operations Required

What you'll need on the ground to run this franchise day-to-day.

Area Required

200 - 250 sq ft

Staff Needed

—

Setup Time

—

Owner Involvement

—

Best Locations

Not published

Business Type

Not published

Training & Support

What the brand provides to help you launch and run your franchise.

Operations Manual

Step-by-step playbook for running the outlet

Not published

Supply Chain Support

Vendor sourcing, inventory & logistics

Not published

Technology / POS

Billing, inventory, and management software

Not published

Marketing Support

National & local marketing campaigns

Not included

Launch Support

Pre-opening setup and grand-opening assistance

Not published

Ongoing Field Support

Regular visits and operational coaching

Not published

What Dr Lal PathLabs franchisees say

We haven't yet heard from enough Dr Lal PathLabs franchisees to show anything. We publish totals once 3 or more people who run an outlet have answered and we've called each one to check.

I run a Dr Lal PathLabs outlet — share how it went

Frequently Asked Questions

What is the total investment for a Dr Lal PathLabs franchise?
Dr Lal PathLabs states an investment of ₹3 lakh–₹4 lakh. Dr Lal PathLabs states a minimum investment of 'around ₹3–4 Lacs' for an exclusive collection centre; it doesn't say what this covers or whether GST is extra.
How does a Dr Lal PathLabs collection centre earn money?
Through a revenue share. The company's 2015 IPO prospectus says it books the full revenue of each franchised collection centre and pays the franchisee its specified share every month. It doesn't publish the share; the franchise page only promises a 'good return on investment'.
How long is a Dr Lal PathLabs franchise agreement, and can I work with another lab after I leave?
The 2015 prospectus says collection-centre agreements are exclusive and typically last five to nine years, and franchisees can't do pathology work themselves or with another lab for two years after the agreement ends. These are the most recent terms the company has published.
Who pays for equipment and staff at a Dr Lal PathLabs collection centre?
The franchisee arranges the premises, provides basic diagnostic equipment and, in some cases, hires phlebotomists and front-office staff. The company gives technical, personnel and marketing support and sometimes supplies consumables (IPO prospectus, 2015).
How much does Dr Lal PathLabs pay its collection centres in total?
Its FY26 consolidated accounts show ₹402.4 Cr in fees to collection centres and channel partners, about 14.6% of revenue from operations. That is a network-wide total across thousands of centres and pick-up points, not what one centre earns.
How are disputes with Dr Lal PathLabs resolved?
The company doesn't publish its current franchise contract. Two partner agreements that reached the Delhi High Court — a 2015 revenue-sharing agreement (venue Delhi) and a 2016 sample-collection MoU (place of arbitration New Delhi) — provide for a sole arbitrator, and the court appointed arbitrators in 2023 and 2024 at the company's request. Neither is shown to be a collection-centre franchise agreement.

Similar Healthcare & Pharmacy Franchises

View All

Interested in

Dr Lal PathLabs